ACLX icon

Arcellx

87.50 USD
+1.47
1.71%
At close Updated Oct 30, 4:00 PM EDT
Pre-market
After hours
87.50
0.00
0%
1 day
1.71%
5 days
3.83%
1 month
6.58%
3 months
22.31%
6 months
34.72%
Year to date
11.11%
1 year
0.79%
5 years
420.83%
10 years
420.83%
 

About: Arcellx Inc a clinical-stage biotechnology company reimagining cell therapy through the development of immunotherapies for patients with cancer and other incurable diseases. Its pipeline includes Multiple Myeloma, Acute Myeloid Leukemia, Non-Oncology, and Solid Tumors.

Employees: 163

0
Funds holding %
of 7,502 funds
0
Analysts bullish %
of 3 analysts
Positive news %
of articles
Price charts implemented using Lightweight Charts™